Arrowstreet Capital, Limited Partnership Gsk PLC Transaction History

Arrowstreet Capital, Limited Partnership

$121 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$42.05 - $47.77 $15.5 Million - $17.6 Million	368,244 Added 3.83%	9,989,614 $435 Million
Q1 2022 May 13, 2022	BUY	$40.23 - $47.74 $95 Million - $113 Million	2,362,274 Added 32.54%	9,621,370 $419 Million
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $137 Million - $160 Million	3,532,684 Added 94.8%	7,259,096 $320 Million
Q3 2021 Nov 12, 2021	BUY	$38.79 - $43.16 $74.8 Million - $83.3 Million	1,929,345 Added 107.36%	3,726,412 $142 Million
Q2 2021 Aug 13, 2021	SELL	$36.52 - $41.46 $35.1 Million - $39.8 Million	-960,551 Reduced 34.83%	1,797,067 $71.6 Million
Q1 2021 May 14, 2021	SELL	$34.27 - $40.01 $154 Million - $180 Million	-4,505,866 Reduced 62.03%	2,757,618 $98.4 Million
Q4 2020 Feb 12, 2021	BUY	$34.07 - $39.94 $112 Million - $132 Million	3,293,574 Added 82.96%	7,263,484 $267 Million
Q3 2020 Nov 12, 2020	SELL	$38.11 - $42.99 $9.11 Million - $10.3 Million	-238,923 Reduced 5.68%	3,969,910 $149 Million
Q2 2020 Aug 12, 2020	BUY	$37.87 - $43.58 $47.6 Million - $54.8 Million	1,256,730 Added 42.57%	4,208,833 $172 Million
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $42.5 Million - $63.9 Million	-1,309,092 Reduced 30.72%	2,952,103 $112 Million
Q4 2019 Feb 13, 2020	SELL	$42.0 - $48.25 $30.8 Million - $35.4 Million	-733,695 Reduced 14.69%	4,261,195 $200 Million
Q3 2019 Nov 14, 2019	SELL	$40.46 - $43.52 $19.7 Million - $21.2 Million	-486,912 Reduced 8.88%	4,994,890 $213 Million
Q2 2019 Aug 14, 2019	SELL	$39.4 - $42.7 $187 Million - $202 Million	-4,739,481 Reduced 46.37%	5,481,802 $219 Million
Q1 2019 May 15, 2019	BUY	$38.57 - $42.69 $66.2 Million - $73.2 Million	1,715,323 Added 20.17%	10,221,283 $427 Million
Q4 2018 Feb 14, 2019	BUY	$37.8 - $42.69 $115 Million - $130 Million	3,053,911 Added 56.01%	8,505,960 $325 Million
Q3 2018 Nov 14, 2018	BUY	$39.75 - $42.69 $213 Million - $229 Million	5,359,449 Added 5787.74%	5,452,049 $219 Million
Q2 2018 Aug 14, 2018	BUY	$39.61 - $42.76 $3.67 Million - $3.96 Million	92,600 New	92,600 $3.73 Million
Q1 2018 May 14, 2018	SELL	$36.18 - $40.15 $26 Million - $28.8 Million	-717,841 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$35.34 - $41.9 $14.4 Million - $17.1 Million	408,441 Added 132.01%	717,841 $25.5 Million
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $12.2 Million - $12.9 Million	309,400	309,400 $12.6 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account